A major breakthrough in cancer study is emerging with the use of nanobodies to re-engage dysfunctional p53. This essential cancer protector protein is frequently disabled in several kinds of malignancies, resulting https://linkingbookmark.com/story21838840/nanobodies-restore-tumor-suppressor-p53-the-potential-hope-for-cancer-management